Kazakh healer's 50-year quest to fight cancer with ancient herbs

A traditional healer from Kazakhstan has spent nearly 50 years treating cancer patients with herbal remedies. Tattibek Zharkynbekov’s methods, developed through decades of trial and error, have drawn attention after some patients achieved long-term remission. His work has also caught the interest of scientists studying local plants for potential anti-cancer properties. Zharkynbekov began his practice in 1982, using a mix of nearly 30 herbs across 12 core formulations. One of his earliest patients, Balkerim B., sought treatment for pelvic bone sarcoma that same year. Over time, he expanded his work, eventually treating hundreds of cancer patients.

Among those who turned to him was Elena S., a Russian woman with an aggressive form of breast cancer. After combining conventional therapy with Zharkynbekov’s herbal treatment, she entered long-term remission. Another patient, Turkish scholar Professor Oner Faruk Karadaulov, received treatment for spinal metastases and reported positive results. Scientific interest in the region’s flora grew alongside Zharkynbekov’s practice. In the 1980s, researchers at the Kazakh SSR’s Institute of Oncology and Radiology examined medicinal plants for their effects on cancer cell growth, finding early promise. Later studies confirmed that one of Zharkynbekov’s herbal compounds showed activity against renal cancer cell lines. Meanwhile, botanists explored the Baidibek District, where he sources many of his ingredients. The formulations themselves evolved through years of testing and adjustment. Zharkynbekov refined his approach by observing patient responses, gradually shaping the remedies still in use today.

Zharkynbekov’s work continues to bridge traditional healing and modern research. His herbal treatments, developed over decades, have helped patients like Elena S. and Professor Karadaulov achieve remission. Scientific studies on local plants suggest some compounds may have real potential against certain cancers, though further research remains necessary.